CVE-2021-1280 Cisco Advanced Malware Protection for Endpoints and Immunet for Windows DLL Hijacking Vulnerability

High 7.8 Published 20 Jan 2021 Updated 12 Nov 2024

Local authenticated attackers can execute arbitrary code with SYSTEM privileges via DLL hijacking in Cisco AMP for Endpoints and Immunet.

Exploited in the wild: Not known
Login needed: Any signed-in user
Attackable: Local or same network only
Victim action needed: Not needed
Fix: None listed

What is CVE-2021-1280?

CVE-2021-1280 is a high-severity path traversal vulnerability in Cisco AMP for Endpoints, published on 20 Jan 2021. It can only be exploited from the same machine or local network, with no action from the victim.

Official description

A vulnerability in the loading mechanism of specific DLLs of Cisco Advanced Malware Protection (AMP) for Endpoints for Windows and Immunet for Windows could allow an authenticated, local attacker to perform a DLL hijacking attack. To exploit this vulnerability, the attacker would need valid credentials on the Windows system. This vulnerability is due to incorrect handling of directory search paths at run time. An attacker could exploit this vulnerability by placing a malicious DLL file on the targeted system. This file will execute when the vulnerable application launches. A successful exploit could allow the attacker to execute arbitrary code on the targeted system with SYSTEM privileges.

Weakness: CWE-427

Which versions are affected by CVE-2021-1280?

It affects 2 products.

Products include Cisco Advanced Malware Protection for Endpoints, Cisco Immunet.

How do I fix CVE-2021-1280?

No fix has been published for CVE-2021-1280 yet. Limit exposure of the affected software until one is available.

Upgrade, and resolve every user-supplied path against an allowed base folder before opening it. More about Path traversal.

Is CVE-2021-1280 being exploited?

There is no known exploitation of CVE-2021-1280 in the wild and no public exploit code.

Sources

Also known as GHSA-674c-q4r5-6548.